Bluestar Adisseo Company Record 2015 Full Year Results
14.04.2016
•
5 min read
Share this post
✅ Link copied to clipboard!
Bluestar Adisseo Company (SSE stock code 600299) or “Adisseo”, world leader in nutritional solutions and additives for animal feed, today announced its financial results for the full year ended December 31, 2015.
KEY FIGURES (amount - % in comparison with 2014 before restatement)
Net profit attributable to the shareholders of the Company after deduction of non-recurring profit or losses
2.6
(10.1)
(10.1)
118%
Basic earnings per share (Yuan/ share)
0.58
0.56
0.47
+17%
Basic earnings per share after deduction of non-recurring profit or loss (Yuan/ share)
0.16
(1.93)
(1.93)
-106%
* 12 months of Adisseo business and 6 months of BNCM business
*** 12 months of Adisseo business and 12 months of BNCM business
*** 12 months of BNCM business
CORPORATE AND BUSINESS HIGHLIGHTS
·Successful asset exchange: Adisseo, WorldWide leader in the health & nutrition segment, replaces BNCM’s assets
·Market share in methionine has improved from 23% in 2012 up to 27% in 2015
·Increase in production capacities in liquid methionine: further capacity expansion of the Nanjing and European plants
·Less favorable market conditions from Q4 2015, as expected
·Continued strategy and reinforced research in innovation and development capabilities
·Strong growth prospects, especially in emerging markets
Jean-Marc Dublanc, CEO of Bluestar Adisseo Company, stated: “Once again in 2015, the Company managed to make progress on many fronts as we fully leveraged our competitive strengths, took effective measures to broaden source of income while looking after production costs, and continued to drive innovation. That is reflected in our economic performance, both in terms of operating revenue and net profit that show a very strong increase compared to last year. As a leader in the industry we are targeting for a sustainable and profitable growth of the company. To achieve this objective we will keep reinforcing our positions in our existing products and also through the development of new products, associated services and next applications.”
A TRANSFORMATIONAL ASSET EXCHANGE
Adisseo has replaced BNCM’s assets through a simultaneous asset exchange. 89.09% of the company is owned by BLUESTAR and remaining minority shareholders represent the floating.
Adisseo, the CHEMCHINA BLUESTAR platform in the health & nutrition segment is now listed.
2015 financial results include 12 months 2015 of Adisseo business and the first 6 months 2015 of BNCM business due to the former entities sold to Bluestar.
2015, A RECORD YEAR
In 2015, Adisseo achieved outstanding results in terms of economic performance.
Adisseo’s operating revenue in 2015 totaled 151.7 (100 million) Yuan, increased by 59% in comparison with last year. It includes the Adisseo business for 122.0 (100 million) Yuan , increased by 45% in comparison with last year at constant EUR/ RMB rateand 23% at current EUR/RMB rate.
Despite the net loss of around 8.9 (100 million) Yuan reported by the BNCM businesses for the first 6 months of 2015 and one shot cost linked to the restructuring, Adisseo recorded a net profit attributable to shareholders of 15.3 (100 million) Yuan due to 24.2 (100 million) Yuan generated by the Adisseo businesses, increased by 50% in comparison with last year.
These financial results were achieved mainly thanks to:
·Strategic investments in development and new products to build a comprehensive and diverse product mix, mainly in specialties, and to satisfy customer’s demand;
·A global production and sales network able to follow or anticipate trends, and manage performance;
·Exceptional methionine market prices due to a short market supply and;
·The positive impact of external factors such as the currency exchange rate and the decrease in the price of Brent oil.
